PHOTO
Mohammad Mostafa will report to Vincenzo Ventricelli, Philips MET CEO
Dubai, UAE – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has appointed Mohammad Mostafa as the new Health Systems General Manager, Philips Middle East & Turkey
Mostafa will lead Philips’ healthcare business in the region as the company continues to drive a value-based approach towards healthcare. With a strong focus on integrated healthcare solutions, Mostafa takes on the responsibility of Philips healthcare’s success and growth in 15 markets across the MET region. He will continue to be based in Saudi Arabia and will report to Ventricelli, Philips MET CEO.
Mohammad Mostafa, General Manager for Health Systems in Philips Middle East & Turkey said, “At a time when the world is facing its toughest ever healthcare challenges, I am honoured to take up my new role. As a leading health technology company, it is our purpose to improve people’s health and well-being through meaningful locally relevant innovations. Driving the business within each country from the region to constantly fulfilling this purpose will be my number one priority. I will be working closely with all our teams and customers to ensure that our integrated healthcare solutions continue to drive the shift towards value-based healthcare – a system that aims to increase access to care and improves patient outcomes at a lower cost.”
Mohammad Mostafa has been leading Philips in Saudi Arabia for the past five years where he led the business to outperform the market. Mostafa joined Philips in 1998 and has held several roles throughout Africa and in the Middle East during his 22-year tenure. As General Manager of Philips Healthcare Egypt / North East Africa, he achieved phenomenal business success across the countries. Mostafa holds two masters degrees in Systems and biomedical engineering as well as in business administration.
For further information:
Philips Middle East and Turkey
Rengin Erdinc rengin.erdinc@philips.com
Impact Porter Novelli
Dana Oraibi D.oraibi@ipn.ae
Shifa Al Usman s.alusman@ipn.ae
About Royal Philips:
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Philips is a market leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Headquartered in the Netherlands, Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. For detailed information: You can visit our website at www.philips.com/newscenter.
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
